After finishing at $10.39 in the prior trading day, Braskem S.A. ADR (NYSE: BAK) closed at $10.90, up 4.91%. On the day, 1186623 shares were traded.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Ratios:
Our goal is to gain a better understanding of BAK by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.02 and its Current Ratio is at 1.53. In the meantime, Its Debt-to-Equity ratio is 15.01 whereas as Long-Term Debt/Eq ratio is at 14.07.
On July 05, 2023, JP Morgan Downgraded its rating to Neutral which previously was Overweight and also lowered its target price recommendation from $11.50 to $11.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BAK now has a Market Capitalization of 4.32B and an Enterprise Value of 12.62B. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.13 while its Price-to-Book (P/B) ratio in mrq is 5.29. Its current Enterprise Value per Revenue stands at 0.17 whereas that against EBITDA is 3.85.
Stock Price History:
Over the past 52 weeks, BAK has reached a high of $12.67, while it has fallen to a 52-week low of $6.30. The 50-Day Moving Average of the stock is 8.12, while the 200-Day Moving Average is calculated to be 8.72.
Shares Statistics:
The stock has traded on average 1.06M shares per day over the past 3-months and 1.68M shares per day over the last 10 days, according to various share statistics. A total of 172.53M shares are outstanding, with a floating share count of 172.20M. Shares short for BAK as of Feb 29, 2024 were 2.55M with a Short Ratio of 1.92, compared to 2.36M on Jan 31, 2024.
Earnings Estimates
Its stock is currently analyzed by 0 different market analysts. On average, analysts expect EPS of $0 for the current quarter, with a high estimate of $0 and a low estimate of $0, while EPS last year was $0.21. The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.
Analysts are recommending an EPS of between -$0.98 and -$0.98 for the fiscal current year, implying an average EPS of -$0.98. EPS for the following year is -$0.04, with 1 analysts recommending between -$0.04 and -$0.04.
Revenue Estimates
A total of 1 analysts have provided revenue estimates for BAK’s current fiscal year. The highest revenue estimate was $14.39B, while the lowest revenue estimate was $14.39B, resulting in an average revenue estimate of $14.39B. In the same quarter a year ago, actual revenue was $14.13B, up 1.90% from the average estimate. Based on 1 analysts’ estimates, the company’s revenue will be $15.16B in the next fiscal year. The high estimate is $15.16B and the low estimate is $15.16B. The average revenue growth estimate for next year is up 5.40% from the average revenue estimate for this year.
